Biological Trace Element Research

, Volume 9, Issue 3, pp 197–205 | Cite as

The effect of chromium supplementation on serum lipid levels in a selected sample of canadian postmenopausal women

  • Diane M. Bourn
  • Rosalind S. Gibson
  • Olga B. Martinez
  • A. Carolyn MacDonald
Original Articles

Abstract

Forty-seven noninstitutionalized, postmenopausal women received 200 μg of Cr (III), in the form of CrCl3 in water, daily, for 10 wk and 39 received placebo (distilled water), in a double-blind experimental design. Serum total cholesterol (total C), HDL cholesterol (HDLC), and triglyceride levels were measured before and after the supplementation period, using enzymatic colorimetric methods. Sixty-three percent of the subjects reported taking medications at the time of the study. Consequently, medicated subjects were classfied into three groups; group 1, those receiving drugs with neutral or unknown effect on serum lipid levels; group 2, those receiving drugs with the potential to decrease serum lipid levels; and group 3, those receiving drugs with the potential to increase serum lipid levels. There were no significant differences in the mean serum total C or triglyceride levels in the nonmedicated or medicated groups, following supplementation with Cr or placebo. In contrast, increases in mean serum HDLC levels were observed in both the Cr-supplemented nonmedicated and medicated groups and the placebo nonmedicated and medicated groups, at the end of the study period. Small decreases in the mean serum total C:HDL ratio also occurred in the nonmedicated Cr-supplemented (p<0.01) and nonmedicated placebo groups. Although our results fail to demonstrate effects of inorganic Cr supplementation on either serum total C, serum HDLC, or serum triglycerides, it is important to point out that this may be a result of, in part, the chosen form and mode of administration of Cr. Additional studies, preferably with food-form sources of Cr, are necessary to establish the role, if any, of Cr on these physiological parameters.

Index Entries

Chromium supplementation double-blind serum total cholesterol serum HDL cholesterol serum triglyceride, non-medicated and medicated subjects postmenopausal women 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. Riales, inChromium in Nutrition and Metabolism, D. Shapcott and J. Hubert, eds., Elsevier/North-Holland Biomedical, 1979, pp. 199–212.Google Scholar
  2. 2.
    R. Nath, J. Minocha, V. Lyall, S. Sunder, V. Kumar, S. Kappor, and K. L. Dhar, inChromium in Nutrition and Metabolism, D. Shapcott and J. Hubert, eds., Elsevier/North-Holland Biomedical, 1979, pp. 213–221.Google Scholar
  3. 3.
    E. G. Offenbacher and F. X. Pi-Sunyer,Diabetes 29, 919 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    R. Riales and M. J. Albrink,Am. J. Clin. Nutr. 34, 2670 (1981).PubMedGoogle Scholar
  5. 5.
    A. P. Grant and J. K. McMullen,Ulster Med. J. 51, 110 (1982).PubMedGoogle Scholar
  6. 6.
    R. T. Mossop,Cent. Afr. Med. J. 29, 80 (1983).Google Scholar
  7. 7.
    J. C. Elwood, D. T. Nash and D. H. P. Streeten,J. Am. Coll. Nutr. 1, 263 (1982).PubMedGoogle Scholar
  8. 8.
    M. C. Wang, E. A. Fox, B. J. Stoecker and C. E. Menendez,Fed. Proc. 43, 471 (1984).Google Scholar
  9. 9.
    G. P. Donzelli, C. Vecchi, P. L. Tucci, G. Poggini and P. Galvan,Diabetologia 21, 265 (1981).Google Scholar
  10. 10.
    M. Cote and D. Shapcott, inTrace Element Metabolism in Man and Animals, J. M. Gawthorne, J. M. C. C. Howell, and C. L. White, eds. (1981).Google Scholar
  11. 11.
    M. I. J. Uusitupa, J. T. Kumpulainen, E. Vollutilainen, K. Hersio, H. Sarlund, K. P. Pynorala, P. E. Koivistoinen and J. T. Lehto,Am. J. Clin. Nutr. 38, 404 (1983).PubMedGoogle Scholar
  12. 12.
    R. A. Anderson, M. M. Polansky, N. A. Bryden, E. E. Roginski, W. Mertz, and W. H. Glinsman,Metabolism 32, 894 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    M. B. Rabinowitz, H. C. Gonick, S. R. Levin, and M. B. Davidson,Diabetes Care 6, 319 (1983).PubMedCrossRefGoogle Scholar
  14. 14.
    W. P. Castelli, J. T. Doyle and T. Gordon,Circulation 55, 767 (1977).PubMedGoogle Scholar
  15. 15.
    H. A. Schroeder,Am. J. Clin. Nutr. 27, 505 (1974).Google Scholar
  16. 16.
    G. Saner,Am. J. Clin Nutr. 34, 853 (1981).PubMedGoogle Scholar
  17. 17.
    Health and Welfare Canada,The Health of Canadians. Report of the Canada Health Survey. Supply and Services Canada and National Health and Welfare, Ottawa, Ontario, (1981).Google Scholar
  18. 18.
    O. B. Martinez, A. C. MacDonald, R. S. Gibson and D. M. Bourn,Nutr. Res. 5, 609 (1985).CrossRefGoogle Scholar
  19. 19.
    C. C. Allain, L. S. Poon, C. S. G. Chan, W. Richmond and P. Fu,Clin. Chem. 20, 470 (1974).PubMedGoogle Scholar
  20. 20.
    M. Burstein, H. R. Scholnick and R. P. Mortin,J. Lipid Res. 11, 583 (1970).PubMedGoogle Scholar
  21. 21.
    A. W. Wahlefeld, inMethods of Enzymatic Analysis, H. U. Bergemeyer, ed., Verlag Chemie Weinheim and Academic, 1974, pp. 1831–1835.Google Scholar
  22. 22.
    W. T. Friedewald, R. I. Levy and D. S. Fredrickson,Clin. Chem. 18, 499 (1972).PubMedGoogle Scholar
  23. 23.
    A. E. Hunt, K. G. D. Allen and B. A. Smith,Fed Proc. 42, 925 (1983).Google Scholar
  24. 24.
    J. A. Vinson and P. Bose,Nutr. Rep. Intern. 30, 911 (1984).Google Scholar

Copyright information

© The Humana Press Inc 1986

Authors and Affiliations

  • Diane M. Bourn
    • 1
  • Rosalind S. Gibson
    • 1
  • Olga B. Martinez
    • 2
  • A. Carolyn MacDonald
    • 1
  1. 1.Applied Human Nutrition, Department of Family StudiesUniversity of GuelphGuelphCanada
  2. 2.Department of NutritionUniversity of GuelphGuelphCanada

Personalised recommendations